Protocol Involvement
- Cocaine Use Reduction with Buprenorphine (CURB) (CTN-0048)
- Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) (CTN-0047)
- Web-delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders (CTN-0044)
- Stimulant Reduction Intervention using Dosed Exercise (CTN-0037)
- Prescription Opioid Addiction Treatment Study (POATS) (CTN-0030)
- A Pilot Study of Osmotic-Release Methylphenidate (OROS-MPH) in Initiating and Maintaining Abstinence in Smokers with Attention Deficit Hyperactivity Disorder (ADHD) (CTN-0029)
- Motivational Enhancement Treatment to Improve Treatment Engagement and Outcome for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse (CTN-0021)
- Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment (CTN-0019)
- Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment (CTN-0018)
- Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment (CTN-0016)
- Women's Treatment for Trauma and Substance Use Disorders (CTN-0015)
- Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs (CTN-0009)
- Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics (CTN-0007)
- Motivational Interviewing (MI) To Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse (CTN-0005)
- Suboxone® (Buprenorphine/Naloxone) Taper: A Comparison of Two Schedules (CTN-0003)
- Buprenorphine/Naloxone (Bup/Nx) versus Clonidine for Outpatient Opiate Detoxification (CTN-0002)
- Buprenorphine/Naloxone (Bup/Nx) versus Clonidine for Inpatient Opiate Detoxification (CTN-0001)
Featured Publication
Drugs, Brains, and Behavior - The Science of Addiction
As a result of scientific research, we know that addiction is a disease that affects both brain and behavior.
